Amicus Therapeutics Aktie
12,10
EUR
+2,85
EUR
+30,81
%
14,17
USD
-0,03
USD
-0,21
%
Werbung
Amicus Therapeutics Aktie Analyse
| 17.08.18 | Amicus Therapeutics Neutral | Chardan Capital Markets | |
| 14.04.16 | Amicus Therapeutics Neutral | Robert W. Baird & Co. Incorporated | |
| 05.10.15 | Amicus Therapeutics Hold | Lake Street | |
| 16.09.15 | Amicus Therapeutics Neutral | Chardan Capital Markets |
Werbung
Werbung